BMS-795311 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as an inhibitor targeting specific kinases involved in cell signaling pathways that are often dysregulated in various cancers. By inhibiting these kinases, BMS-795311 helps researchers understand the mechanisms of tumor growth and progression, making it a valuable tool in the development of targeted cancer treatments. Additionally, it is used in preclinical studies to evaluate its efficacy and safety profile, paving the way for potential therapeutic applications in oncology.